Investors Urged to Join Securities Fraud Class Action Against GRAIL
With an August 4 deadline approaching, the law firm Schall, Brown & Schwartz is calling on shareholders who purchased GRAIL, Inc. stock between May 2025 and February 2026 to come forward. The move follows a class action complaint alleging the company misled the market regarding its high-profile NHS-Galleri cancer trial.






















